[Retracted] Efficacy of TACE+Radiofrequency Ablation+Sorafenib in the Treatment of Patients with Recurrent Liver Cancer and Construction of Prediction Model

Table 1

Comparison of clinical efficacy between the two groups [ (%)].

Group	CR	PR	SD	PD	ORR	DCR
Group A ()	1 (3.33)	9 (30.00)	11 (36.67)	9 (30.00)	10 (33.33)	21 (70.00)
Group B ()	0 (0.00)	3 (10.00)	10 (33.33)	17 (56.67)	3 (10.00)	13 (43.33)
-value					4.812	4.344
value					0.028	0.037

CR: complete remission; PR: partial remission; SD: stable disease; PD progressive disease; ORR: objective response rate; DCR: (disease control rate).